AV
TECH icon

ASR Vermogensbeheer’s Bio-Techne TECH Stock Holding History

ASR Vermogensbeheer’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,511
Closed -$140K – 568
2025
Q3 		$140K Sell
2,511
-29
-1% -$1.55K ﹤0.01% 547
2025
Q2 		$131K Sell
2,540
-13
-0.5% -$653 ﹤0.01% 552
2025
Q1 		$150K Buy
+2,553
New +$173K ﹤0.01% 560

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

ASR Vermogensbeheer's TECH Position: Q4 2025 in Review

ASR Vermogensbeheer sold out of Bio-Techne (TECH) in Q4 2025, closing a stake of 2,511 shares — an estimated $140K sold.

ASR Vermogensbeheer first reported a position in TECH in Q1 2025 and held it in 3 quarters. The position peaked at $150K in Q1 2025. 586 funds tracked by Wall St. Rank hold TECH as of Q4 2025.

  • ASR Vermogensbeheer reported no remaining Bio-Techne position as of Q4 2025 after selling out during the quarter.
  • ASR Vermogensbeheer sold 2,511 Bio-Techne shares in Q4 2025, an estimated $140K.
  • ASR Vermogensbeheer first reported a position in Bio-Techne in Q1 2025 and held it in 3 quarters.
  • ASR Vermogensbeheer's Bio-Techne position peaked at $150K in Q1 2025.
  • 586 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2025.

Based on ASR Vermogensbeheer's 13F filing for Q4 2025, filed 3 Feb 2026.